z-logo
open-access-imgOpen Access
A Case of Primary Signet-Ring Cell Cervical Carcinoma Treated with Chemoradiation, Brachytherapy, and Adjuvant Hysterectomy
Author(s) -
Nicole Salmen,
Dominic LaBella,
Kenneth B. Strumpf,
W.D. Bunn,
Paul Aridgides
Publication year - 2021
Publication title -
case reports in obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2090-6684
pISSN - 2090-6692
DOI - 10.1155/2021/5544015
Subject(s) - medicine , signet ring cell , signet ring cell carcinoma , cervix , adenocarcinoma , brachytherapy , radiation therapy , hysterectomy , pathology , oncology , radiology , cancer
Primary signet-ring cell carcinoma of the uterine cervix is a rare subtype of cervical mucinous adenocarcinoma. Approximately 20 cases of primary signet-ring cell carcinoma of the cervix have been reported. Pathologic examination shows that adenocarcinomas with mucin accumulation in intracytoplasmic vacuoles displacing the nucleus indicate signet-ring cell carcinoma. A thorough metastatic workup is needed both for staging and to rule out gastrointestinal tract origin. Due to the rarity of the disease, both the true incidence and optimal management are unknown. Herein, the authors present a case of stage 1B3 primary signet-ring cell cervical carcinoma treated with combined chemotherapy and radiation (including external beam radiation and brachytherapy), followed by resection for residual disease. This case is consistent with limited reports where all surviving patients received surgery as well as 1 surviving patient with bulky disease required with chemoradiation and adjuvant hysterectomy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom